In accordance with the above, in a systematic review and meta-analysis previously published by our research team, we found that, after oral administration of RV, glucose, insulin, HbA1c, and HOMA-IR levels decrease in subjects with T2DM; however, the age-related effective dose could not be ascertained [12]. This evidence concerns the gene INS and type 2 diabetes mellitus.